Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

Clinical trial NCT02621164 · COMPLETED

Trial details

NCT number: NCT02621164
Sponsor: SK Chemicals Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2014-09-01
Primary completion: 2015-02-01
Enrollment: 454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.